|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the furnishing by pharmacists and dispensing by |
|
physicians of certain medications. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 483.001(11), Health and Safety Code, is |
|
amended to read as follows: |
|
(11) "Practice of pharmacy" has the meaning assigned |
|
by Section 551.003, Occupations Code [means: |
|
[(A) provision of those acts or services |
|
necessary to provide pharmaceutical care; |
|
[(B) interpretation and evaluation of |
|
prescription drug orders or medication orders; |
|
[(C) participation in drug and device selection |
|
as authorized by law, drug administration, drug regimen review, or |
|
drug or drug-related research; |
|
[(D) provision of patient counseling; |
|
[(E) responsibility for: |
|
[(i) dispensing of prescription drug orders |
|
or distribution of medication orders in the patient's best |
|
interest; |
|
[(ii) compounding and labeling of drugs and |
|
devices, except labeling by a manufacturer, repackager, or |
|
distributor of nonprescription drugs and commercially packaged |
|
prescription drugs and devices; |
|
[(iii) proper and safe storage of drugs and |
|
devices; or |
|
[(iv) maintenance of proper records for |
|
drugs and devices. In this subdivision, "device" has the meaning |
|
assigned by Subtitle J, Title 3, Occupations Code; or |
|
[(F) performance of a specific act of drug |
|
therapy management for a patient delegated to a pharmacist by a |
|
written protocol from a physician licensed by the state under |
|
Subtitle B, Title 3, Occupations Code]. |
|
SECTION 2. Section 157.002(f), Occupations Code, is amended |
|
to read as follows: |
|
(f) Subsections (b) and (c) do not authorize a physician or |
|
a person acting under the supervision of a physician to keep a |
|
pharmacy, advertised or otherwise, for the retail sale of dangerous |
|
drugs, other than as authorized under Section 158.003 or 158.004, |
|
without complying with the applicable laws relating to the |
|
dangerous drugs. |
|
SECTION 3. Subchapter C, Chapter 157, Occupations Code, is |
|
amended by adding Section 157.102 to read as follows: |
|
Sec. 157.102. DELEGATION TO PHARMACIST TO FURNISH CERTAIN |
|
DRUGS. (a) In this section: |
|
(1) "Acute condition" means a condition or disease |
|
that begins abruptly, intensifies rapidly, and is generally not |
|
long-lasting. |
|
(2) "Pharmacist" has the meaning assigned by Section |
|
551.003. |
|
(3) "Waived clinical laboratory test" means a clinical |
|
laboratory test that is classified as waived under federal |
|
regulations issued under the Clinical Laboratory Improvement |
|
Amendments of 1988 (42 U.S.C. Section 263a). |
|
(4) "Written protocol" means a physician's written |
|
order, standing medical order, standing delegation order, or other |
|
order or protocol as defined by rule of the board. |
|
(b) Notwithstanding any other law, a pharmacist may furnish |
|
to a patient a prescription drug: |
|
(1) as provided by a physician's written protocol, to |
|
treat an acute condition that is identified through performance of |
|
one of the following tests, if the test is a waived clinical |
|
laboratory test: |
|
(A) a rapid strep test or rapid antigen detection |
|
test used in the identification of group A streptococcus (GAS); |
|
(B) a rapid influenza diagnostic test used in the |
|
identification of influenza types A and B; or |
|
(C) a rapid molecular or antigen detection test |
|
used in the identification of the SARS-CoV-2 (COVID-19) virus; or |
|
(2) the furnishing of which is authorized by an |
|
emergency rule adopted under an executive order or emergency |
|
authorization. |
|
(c) The board shall adopt rules jointly with the Texas State |
|
Board of Pharmacy to establish the minimum content of the written |
|
protocol required under Subsection (b). The written protocol may |
|
permit a pharmacist to furnish a prescription drug to a patient |
|
without an established physician-patient relationship. |
|
(d) A written protocol under this section must require |
|
notice to the patient's primary care physician, as identified by |
|
the patient if the patient has a primary care physician, and |
|
prescribe the period for providing the notice and the form of the |
|
notice, in accordance with prevailing practices for the provision |
|
of notice to a patient's primary care physician. The period for |
|
providing the notice may not be later than the 14th day after the |
|
date the drug is furnished by the pharmacist. |
|
(e) The board and the Texas State Board of Pharmacy shall |
|
enter into a memorandum of understanding regarding the regulation |
|
of pharmacists who furnish prescription drugs to patients under |
|
this section. The memorandum of understanding must be adopted by |
|
rule and provide that: |
|
(1) a pharmacist who furnishes prescription drugs to a |
|
patient under this section is subject only to the disciplinary |
|
authority of the Texas State Board of Pharmacy; and |
|
(2) an inspection of the practice location of a |
|
pharmacist who furnishes prescription drugs to a patient under this |
|
section must be conducted by the Texas State Board of Pharmacy. |
|
SECTION 4. Chapter 158, Occupations Code, is amended by |
|
adding Section 158.004 to read as follows: |
|
Sec. 158.004. DISPENSING OF CERTAIN DRUGS. (a) In this |
|
section, "acute condition" and "waived clinical laboratory test" |
|
have the meanings assigned by Section 157.102. |
|
(b) Notwithstanding any other law, a physician may dispense |
|
to the physician's patient a prescription drug: |
|
(1) to treat an acute condition that is identified |
|
through performance of one of the following tests, if the test is a |
|
waived clinical laboratory test: |
|
(A) a rapid strep test or rapid antigen detection |
|
test used in the identification of group A streptococcus (GAS); |
|
(B) a rapid influenza diagnostic test used in the |
|
identification of influenza types A and B; or |
|
(C) a rapid molecular or antigen detection test |
|
used in the identification of the SARS-CoV-2 (COVID-19) virus; |
|
(2) that is an antibiotic; or |
|
(3) the dispensing of which is authorized by an |
|
emergency rule adopted under an executive order or emergency |
|
authorization. |
|
(c) The board and the Texas State Board of Pharmacy shall |
|
enter into a memorandum of understanding regarding the regulation |
|
of physicians who dispense prescription drugs to the physicians' |
|
patients under this section. The memorandum of understanding must |
|
be adopted by rule and provide that: |
|
(1) a physician who dispenses prescription drugs to |
|
the physician's patient under this section is subject only to the |
|
disciplinary authority of the board; and |
|
(2) an inspection of the practice location of a |
|
physician who dispenses prescription drugs to the physician's |
|
patient under this section must be conducted by the board. |
|
SECTION 5. Section 551.003(33), Occupations Code, is |
|
amended to read as follows: |
|
(33) "Practice of pharmacy" means: |
|
(A) providing an act or service necessary to |
|
provide pharmaceutical care; |
|
(B) interpreting or evaluating a prescription |
|
drug order or medication order; |
|
(C) participating in drug or device selection as |
|
authorized by law, and participating in drug administration, drug |
|
regimen review, or drug or drug-related research; |
|
(D) providing patient counseling; |
|
(E) being responsible for: |
|
(i) dispensing a prescription drug order or |
|
distributing a medication order; |
|
(ii) compounding or labeling a drug or |
|
device, other than labeling by a manufacturer, repackager, or |
|
distributor of a nonprescription drug or commercially packaged |
|
prescription drug or device; |
|
(iii) properly and safely storing a drug or |
|
device; or |
|
(iv) maintaining proper records for a drug |
|
or device; |
|
(F) performing for a patient a specific act of |
|
drug therapy management delegated to a pharmacist by a written |
|
protocol from a physician licensed in this state in compliance with |
|
Subtitle B; [or] |
|
(G) administering an immunization or vaccination |
|
under a physician's written protocol; or |
|
(H) furnishing a prescription drug to a patient |
|
under a physician's written protocol under Section 157.102. |
|
SECTION 6. Section 551.004(b), Occupations Code, is amended |
|
to read as follows: |
|
(b) This subtitle does not prevent a practitioner from: |
|
(1) administering a drug to a patient of the |
|
practitioner; or |
|
(2) dispensing a prescription drug to a patient as |
|
provided by Section 158.004. |
|
SECTION 7. Subchapter B, Chapter 562, Occupations Code, is |
|
amended by adding Section 562.058 to read as follows: |
|
Sec. 562.058. TRAINING REQUIRED TO FURNISH CERTAIN DRUGS. |
|
(a) A pharmacist may not furnish a prescription drug under Section |
|
157.102 unless the pharmacist has completed a training program that |
|
is approved by the board and is relevant to the condition treated by |
|
the drug. |
|
(b) The board shall adopt rules jointly with the Texas |
|
Medical Board to establish the minimum content of the training |
|
program required under Subsection (a). |
|
SECTION 8. Section 563.051(d), Occupations Code, is amended |
|
to read as follows: |
|
(d) This section does not authorize a physician or a person |
|
acting under the supervision of a physician to keep a pharmacy, |
|
advertised or otherwise, for the retail sale of dangerous drugs, |
|
other than as authorized under Section 158.003 or 158.004, without |
|
complying with the applicable laws relating to the dangerous drugs. |
|
SECTION 9. Not later than January 1, 2024, the Texas State |
|
Board of Pharmacy and the Texas Medical Board shall adopt the rules |
|
required under Sections 157.102, 158.004, and 562.058, Occupations |
|
Code, as added by this Act. |
|
SECTION 10. This Act takes effect September 1, 2023. |